We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Gamma Interferon Also Fights Fungal Infections

By HospiMedica staff writers
Posted on 13 Nov 2007
Interferon, a known cure for viral infections, may also be a strong weapon in the battle against fungal infections in immuno-compromised patients, according to a new study.

Researchers at Stanford University (CA, USA) found that when gamma interferon was given to mice infected with Cryptococcus along with amphotericin B--a standard antifungal treatment--the rate of cure was significantly higher than using one therapy alone. More...
Further tests on other fungal infections, including blastomycosis, candidosis, and aspergillosis showed that gamma interferon, when used as an adjunctive therapy, has beneficial effects in terms of the reduction of the fungus in the organs and on animal survival. The researchers found that Gamma interferon works by enhancing the mechanisms of neutrophils, converting them into more potent killers of fungi. The researchers also explored the possibility of using gene therapy for delivering gamma interferon into the nervous system to combat fungal meningitis. The study was published in the November 2007 issue of Microbiology Today.

"Studies of this type suggest a potential clinical use for specific gamma interferon gene therapy in the future,” said co-author Dr. David Stevens of the division of infectious diseases and geographic medicine. "Treatment with gamma-interferon offers a new additional approach to treatment and it provides a new approach to treating difficult diseases. However, clinical trials must document the benefit for patients.”

Interferons (IFNs) are natural proteins that belong to the large class of glycoproteins known as cytokines that are produced by the cells of the immune system in response to challenges by foreign agents such as viruses, bacteria, parasites, and tumor cells. Interferons assist the immune response by suppressing virus reproduction, stimulating other T cells, and activating macrophage cells.


Related Links:
Stanford University

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.